Home » Piramal in Talks to Buy U.S. Contract Drugmaker Cambridge for $200 Million
Piramal in Talks to Buy U.S. Contract Drugmaker Cambridge for $200 Million
Piramal Healthcare is in talks to buy U.S. contract drug manufacturer Cambridge Major Laboratories for around $200 million, a person with direct knowledge of the development said.
The Financial Express
The Financial Express
Upcoming Events
-
07May
-
14May
-
30May